相关实验视频

Updated: Jan 10, 2026

Basophil Activation Test for Allergy Diagnosis

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

自主功能测试和症状严重程度在怀疑巨细胞激活障碍的患者

Amro M Stino¹, Jodi Nelson¹, Olivia Gutgsell¹

¹Department of Neurology, University of Michigan, UH South F2647, 1500 E. Medical Center Dr., Ann Arbor, MI, 48109, USA.

Autonomic neuroscience : basic & clinical

|November 20, 2025

概括

患有巨细胞激活障碍 (MCAD) 的患者会出现轻微的客观但中度至严重的主观自主症状. 遗传性alpha tryptasemia (HaT) 与较不严重的客观自主措施相关.

科学领域:

巨细胞激活障碍巨细胞激活障碍
自主神经系统功能自主神经系统功能
血液学血液学血液学

背景情况:

乳腺细胞激活障碍 (MCAD),包括遗传性alpha tryptasemia (HaT) 和全身性乳腺细胞瘤,越来越被认可.
脱自主性,或自主功能障碍,可以显著影响这些患者的生活质量.
对于MCAD和相关疾病存在正式的分类标准.

研究的目的:

在患有MCAD,HaT和全身性巨细胞瘤的患者中评估自主神经系统的严重程度.
为了比较这些人群中自主功能障碍的客观和主观措施.
确定特定的MCAD分类与自主性疾病严重程度之间的关联.

主要方法:

对客观自主功能测试的评估.
评估主观患者报告的自主性症状严重程度.
从正式分类的MCAD,HaT和全身性巨细胞瘤患者的数据分析.

主要成果:

在所有患者群体中,自主性疾病的严重程度在客观上是温和的.
主观测量表明所有受试者的自主功能障碍中度至严重.
存在MCAD并没有持续改变主观或客观的严重程度.
高血压与较低的客观,但不是主观的自主性严重程度指标有关.

结论:

正式的分类标准适用于评估MCAD和相关疾病.
在MCAD患者中疑似的dysautonomia需要全面的检查.
纳入客观和主观的措施对于评估在这些条件下自主功能障碍至关重要.

关键词:

在CASS CASS CASS中使用.一个指南针指南针.疾病严重程度疾病严重程度这种自主性很差.遗传性阿尔法三酸血症遗传性阿尔法三酸血症巨细胞激活激活过程

更多相关视频

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Quantitative Autonomic Testing

Quantitative Autonomic Testing

Published on: July 19, 2011

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

Asthma-IV: Diagnostic and Management

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

Angina III: Clinical Manifestations and Assessment

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...